30 March 2026 – Today, Doctors Without Borders/Médecins Sans Frontières (MSF) sent an open letter to the US pharmaceutical corporation Gilead Sciences, calling on the company to immediately sell to MSF, lenacapavir, an HIV medicine
With 75% of deaths related to NCDs and mental health conditions in low- and middle-income countries – accounting for 32 million lives lost each year – affordable access to key medical tools should be a
In the Central African Republic, living with diabetes is a real challenge. Access to treatment is limited, medicines such as insulin are expensive and often difficult to find, and structured patient care programmes are rare.
Cox’s Bazar, Bangladesh – 22 May 2025 – To address concerningly high levels of hepatitis C in the Rohingya refugee camps in Cox’s Bazar, Bangladesh, 30,000 people will receive care by the end of 2026
Diabetes ranks among the top 10 causes of death globally and affects over half a billion people worldwide. Over 80% of those affected live in low- and middle-income countries (LMICs). Insulin pens and newer diabetes
Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali,
80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors
Bihar, India– Since 2019, Médecins Sans Frontières (MSF) has been actively working in Bihar to provide crucial support to individuals living with advanced HIV at Guru Gobind Singh Hospital in Patna. This vulnerable population confronts
Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot Munich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for
Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported
The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn
As an international medical humanitarian organisation, Médecins Sans Frontières/Doctors Without Borders (MSF) has repeatedly witnessed how the world’s most vulnerable people are left without access to the lifesaving medicines, diagnostics tests and vaccines they need.
Sign up for our emails and get deeper insight into world and work of MSF!
